{"type":"trials","record":{"id":36122,"source_id":"clinicaltrials-gov","external_id":"NCT04569487","title":"Identification of Relevant Biological, Imaging, Mobility and Clinical Markers for Clinical Research in Sarcopenia","brief_summary":"The objective of this trial is to constitute a cohort of sarcopenic versus non-sarcopenic patients to validate the most relevant biological, imaging, mobility and clinical markers considered individually or in association for the diagnosis of sarcopenic patients.","overall_status":"Completed","phases":[],"study_type":"INTERVENTIONAL","sponsor":"Artialis","enrollment":16,"countries":["Belgium"],"start_date":"2021-02-11","completion_date":"2024-04-02","last_update_date":"2024-07-31","source_url":"https://clinicaltrials.gov/study/NCT04569487","editorial_summary":"A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.","first_seen_at":"2026-09-25T01:20:24.196666+00:00","last_seen_at":"2026-09-25T06:10:25.747+00:00","metadata":{"sex":"MALE","acronym":null,"age_range":"65 Years","comparator":"Sarcopenic population; Non sarcopenic population","organization":"Artialis","interventions":["Biopsy"],"registry_source":"ClinicalTrials.gov","outcome_measures":["Identified soluble markers of sarcopenia — 3 months after biopsy","Identified imaging marker — within 15 days after Day 0 (baseline visit)","Determine thePhysical performance — Day 0 (baseline visit)","Determine the falls risk — Day 0 (baseline visit)","Identified clinical marker — Day 0 (baseline visit)","Determine the muscle strength — Day 0 (baseline visit)","Evaluate the quality of life — Day 0 (baseline visit)","Determine cognitive performance — Day 0 (baseline visit)","Determine the nutrition status — Day 0(baseline visit)","Evaluate the tolerance — 3 months (baseline visit to biopsy)"],"design_description":"NON RANDOMIZED · PARALLEL · DIAGNOSTIC · NONE","source_has_results":false},"controlled_terms":["Sarcopenia","Biopsy"],"relevance_confidence":100,"source_quality_score":100,"freshness_score":65,"publication_state":"published","match_explanation":"Title contains controlled term: sarcopenia.","quality_checked_at":"2026-09-25T06:10:37.875473+00:00","duplicate_cluster_key":"id:nct04569487","duplicate_of_id":null,"evidence_snapshot":{"status":"structured","version":1,"duration":"2021-02-11 to 2024-04-02","comparator":"Sarcopenic population; Non sarcopenic population","confidence":"structured-source","population":"MALE · 65 Years","provenance":{"duration":"start_date and completion_date","comparator":"registry arm fields","population":"registry eligibility fields","intervention":"registry intervention fields","participants":"enrollment","study_design":"study_type and registry design fields","evidence_stage":"phases","reported_outcome":"not available","outcomes_measured":"registry outcome-measure fields"},"generated_at":"2026-09-25T06:10:25.842Z","intervention":["Biopsy"],"participants":16,"study_design":"NON RANDOMIZED · PARALLEL · DIAGNOSTIC · NONE","subject_scope":"Human clinical study registration","evidence_stage":"Phase not reported","safety_context":"Eligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians.","source_support":"Structured registry protocol metadata; no finding-level conclusion is generated.","main_limitation":"This is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.","reported_outcome":null,"outcomes_measured":["Identified soluble markers of sarcopenia — 3 months after biopsy","Identified imaging marker — within 15 days after Day 0 (baseline visit)","Determine thePhysical performance — Day 0 (baseline visit)","Determine the falls risk — Day 0 (baseline visit)","Identified clinical marker — Day 0 (baseline visit)","Determine the muscle strength — Day 0 (baseline visit)","Evaluate the quality of life — Day 0 (baseline visit)","Determine cognitive performance — Day 0 (baseline visit)","Determine the nutrition status — Day 0(baseline visit)","Evaluate the tolerance — 3 months (baseline visit to biopsy)"],"regulatory_context":"Trial registration is not regulatory approval and does not establish that an intervention is available."},"clinical_trial_topics":[{"topic_slug":"sarcopenia","is_published":true,"match_reasons":["Title contains controlled term: sarcopenia.","Source terminology contains: sarcopenia.","Title supplies longevity context: aging.","Study type is explicitly identified as INTERVENTIONAL."],"matched_fields":["title","controlled terminology","title context","study type"],"relevance_score":100,"intelligence_topics":{"name":"Sarcopenia","slug":"sarcopenia"}}],"content_sources":{"name":"ClinicalTrials.gov","homepage_url":"https://clinicaltrials.gov/"}},"canonical_url":"https://www.immortal.life/trials/36122","automation_disclosure":"Generated automatically from cited source metadata. No scientist, clinician, researcher, editor, or human reviewer evaluates this publication before release."}